Evidence map›Paper›PMID 33891621›Full record

ArticlePloS one2021

Platelet association with leukocytes in active eosinophilic esophagitis.

Kelly A Bartig, Kristine E Lee, Deane F Mosher, Sameer K Mathur, Mats W Johansson

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02775045 (Eosinophil β1 Integrin Activation as a Biomarker for Eosinophilic Esophagitis), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02775045 completednot on this map

Eosinophil β1 Integrin Activation as a Biomarker for Eosinophilic Esophagitis

TypeobservationalSponsorUniversity of Wisconsin, MadisonRan2016 to 2018Enrolled28ConditionsEosinophilic EsophagitisArmsObservation Period
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kelly A BartigDepartment of Biomolecular Chemistry, University of Wisconsin, Madison, Wisconsin, United States of America.
Kristine E LeeDepartment of Biostatistics and Medical Informatics, University of Wisconsin, Madison, Wisconsin, United States of America.
Deane F MosherDepartment of Biomolecular Chemistry, University of Wisconsin, Madison, Wisconsin, United States of America.
Sameer K MathurDepartment of Medicine, University of Wisconsin, Madison, Wisconsin, United States of America.
Mats W JohanssonDepartment of Biomolecular Chemistry, University of Wisconsin, Madison, Wisconsin, United States of America.ORCID 0000-0001-5699-978X
University of Wisconsin–Madison · US

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Christian Capitini · 1985 to 2026
$142.6M
University of Wisconsin Institute for Clinical and Translational ResearchUL1TR002373 · NCATS · UNIVERSITY OF WISCONSIN-MADISON · PI ELIZABETH S BURNSIDE, Allan R. Brasier · 2017 to 2026
$75.9M
INSTITUTIONAL CTSA (UW-MADISON): CLINICAL TRIALSUL1RR025011 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI DREZNER, MARC KENNETH · 2007 to 2011
$29.5M
Eosinophil beta1 integrin activation as a biomarker for eosinophilic esophagitisR21AI122103 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI MATHUR, SAMEER K · 2016 to 2017
$421k
NCATS NIH HHS UL1 TR002373NCI NIH HHS P30 CA014520NCRR NIH HHS UL1 RR025011NIAID NIH HHS R21 AI122103
6 · The paper itself

Abstract

We previously demonstrated that the percentage of blood eosinophils that are associated with platelets and thus positive for CD41 (integrin αIIb-subunit) correlates with and predicts peak eosinophil count (PEC) in biopsies of eosinophilic esophagitis (EoE) patients after treatment. Thus, flow cytometric determination of CD41+ eosinophils is a potential measure of EoE disease activity. Determinants of association of platelets with eosinophils and other leukocytes in EoE are largely unknown. The objectives of this study were to test the hypotheses that platelets associate with blood leukocytes other than eosinophils in EoE and that such associations also predict EoE activity. Whole blood flow cytometry was performed on samples from 25 subjects before and after two months of standard of care EoE treatment. CD41 positivity of cells within gates for eosinophils, neutrophils, monocytes, lymphocytes, and natural killer cells was compared. We found that percent CD41+ neutrophils, monocytes, and eosinophils correlated with one another such that principal component analysis of the five cell types identified "myeloid" and "lymphoid" factors. Percent CD41+ neutrophils or monocytes, or the myeloid factor, like CD41+ eosinophils, correlated with PEC after treatment, and CD41+ neutrophils or the myeloid factor predicted PEC < 6/high power field after treatment, albeit with lower area under the curve than for CD41+ eosinophils. We conclude that the processes driving platelets to associate with eosinophils in EoE also drive association of platelets with neutrophils and monocytes and that association of platelets with all three cell types is related to disease activity. Clinicaltrials.gov identifier: NCT02775045.

Indexed as

Flow CytometryAdultAntibodiesBlood PlateletsEosinophilic EsophagitisEosinophilsFemaleHumansKiller Cells, NaturalLeukocyte CountLeukocytesLymphocytesMaleMonocytesNeutrophilsPlatelet Membrane Glycoprotein IIbAntibodiesPlatelet Membrane Glycoprotein IIb

Identifiers

PMID33891621
PMCPMC8064567
OpenAlexW3156990845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.